Asclemed USA Inc. recalls

4 recalls.

• Lidolog Kit recall (Asclemed USA Inc.)
  DrugClass IIIReported July 29, 2026 · Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
• Lidocaine HCl Injection USP recall (Asclemed USA Inc.)
  DrugClass IIReported July 8, 2026 · Lack of Assurance of Sterility
• Accucaine recall (Asclemed USA Inc.)
  DrugClass IIReported July 8, 2026 · Lack of Assurance of Sterility
• Duloxetine DR Capsules recall (Asclemed USA Inc.)
  DrugClass IIReported June 10, 2026 · CGMP Deviations; presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the FDA acceptable intake limit.